Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Revakinagene taroretcel by Neurotech Pharmaceuticals for Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT): Likelihood of Approval
Revakinagene taroretcel is under clinical development by Neurotech Pharmaceuticals and currently in Pre-Registration for Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT). According...